Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimada

Showing results (291-300 of 360) with videos related to

Pageof 36
Sort By:
Blood|July 11, 2012
Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndromeTakashi Taga, Akiko Moriya Saito, Kazuko Kudo, et al.
Diabetology International|January 29, 2025
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International|August 5, 2024
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Journal of Diabetes Investigation|November 12, 2024
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Pediatric Blood & Cancer|September 29, 2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R studyHiroshi Moritake, Shiro Tanaka, Takako Miyamura, et al.
British Journal of Haematology|May 11, 2012
De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristicsOlfat Ismael, Akira Shimada, Asahito Hama, et al.
The Journal of Medical Investigation : JMI|April 23, 2026
Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA studyShuichiro Saito, Yushi Hirota, Akane Yamamoto, et al.
Journal of Diabetes Investigation|January 7, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International|January 24, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
The Tokai Journal of Experimental and Clinical Medicine|August 27, 2023
Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA StudyMasao Toyoda, Takashi Murata, Yushi Hirota, et al.
Pageof 36

Showing results (291-300 of 360) with videos related to

Sort By:
Pageof 36
Blood|July 11, 2012
Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndromeTakashi Taga, Akiko Moriya Saito, Kazuko Kudo, et al.
Diabetology International|January 29, 2025
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International|August 5, 2024
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Journal of Diabetes Investigation|November 12, 2024
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Pediatric Blood & Cancer|September 29, 2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R studyHiroshi Moritake, Shiro Tanaka, Takako Miyamura, et al.
British Journal of Haematology|May 11, 2012
De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristicsOlfat Ismael, Akira Shimada, Asahito Hama, et al.
The Journal of Medical Investigation : JMI|April 23, 2026
Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA studyShuichiro Saito, Yushi Hirota, Akane Yamamoto, et al.
Journal of Diabetes Investigation|January 7, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International|January 24, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
The Tokai Journal of Experimental and Clinical Medicine|August 27, 2023
Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA StudyMasao Toyoda, Takashi Murata, Yushi Hirota, et al.
Pageof 36